Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000200441 | SCV000252181 | uncertain significance | not provided | 2016-10-11 | criteria provided, single submitter | clinical testing | p.Glu51Gly (GAA>GGA): c.152 A>G in exon 3 of the RARS2 gene (NM_020320.3) A variant of unknown significance has been identified in the RARS2 gene. The E51G variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The E51G variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is moderately conserved across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant.The variant is found in MITONUC-MITOP panel(s). |
Natera, |
RCV001273019 | SCV001455547 | uncertain significance | Pontocerebellar hypoplasia type 6 | 2020-09-16 | no assertion criteria provided | clinical testing |